Laboratory tests suggest a new drug may prove effective in tackling three types of childhood cancer, a scientific conference has heard.The drug RH1 was able to kill tumour cells from neuroblastoma, osteosarcoma and Ewing’s sarcoma, all of which can be resistant to current treatment.
